SD Biosensor Inc Financial Flexibility Index
SD Biosensor Inc financial flexibility index. SD Biosensor Inc (137310) has a Financial Flexibility Index of 0.02x as of June 2026. Free cash flow of ₩10.58 Billion (operating CF ₩1.55 Billion minus capex ₩9.03 Billion) represents 0% of total liabilities (₩495.94 Billion). Explore capital reinvestment ratio of SD Biosensor Inc to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SD Biosensor Inc (2019–2025)
Financial flexibility index of SD Biosensor Inc from 2019 to 2025. Historical Financial Flexibility Index trend for SD Biosensor Inc across 7 annual periods. Check SD Biosensor Inc (137310) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SD Biosensor Inc Financial Flexibility Index by Year (2019–2025)
SD Biosensor Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for SD Biosensor Inc. For the full cash flow conversion analysis, see 137310 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | ₩415.01 Billion | ₩357.52 Billion | ₩905.85 Billion | ▲ +84.5% |
| 2024 | 0.25x | ₩237.43 Billion | ₩156.53 Billion | ₩956.18 Billion | ▲ +343.5% |
| 2023 | -0.10x | ₩-97.63 Billion | ₩-242.32 Billion | ₩957.28 Billion | ▼ -102.7% |
| 2022 | 3.78x | ₩1.19 Trillion | ₩890.23 Billion | ₩315.14 Billion | ▲ +112.6% |
| 2021 | 1.78x | ₩1.42 Trillion | ₩1.23 Trillion | ₩801.72 Billion | ▲ +127.4% |
| 2020 | 0.78x | ₩550.29 Billion | ₩495.38 Billion | ₩704.10 Billion | ▲ +326.6% |
| 2019 | 0.18x | ₩5.83 Billion | ₩-1.62 Billion | ₩31.80 Billion | — |